Vanguard Personalized Indexing Management
PRQR icon

Vanguard Personalized Indexing Management’s ProQR Therapeutics PRQR Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.1K Buy
22,095
+2,685
+14% +$4.42K ﹤0.01% 2159
2026
Q1 		$31.4K Sell
19,410
-2,904
-13% -$4.76K ﹤0.01% 2093
2025
Q4 		$45.1K Hold
22,314
– – ﹤0.01% 1893
2025
Q3 		$47.5K Hold
22,314
– – ﹤0.01% 1905
2025
Q2 		$45.5K Buy
22,314
+1,518
+7% +$2.47K ﹤0.01% 1839
2025
Q1 		$27.7K Sell
20,796
-633
-3% -$1.35K ﹤0.01% 1737
2024
Q4 		$56.8K Hold
21,429
– – ﹤0.01% 1681
2024
Q3 		$39K Hold
21,429
– – ﹤0.01% 1699
2024
Q2 		$35.6K Hold
21,429
– – ﹤0.01% 1610
2024
Q1 		$49.1K Hold
21,429
– – ﹤0.01% 1566
2023
Q4 		$42.4K Hold
21,429
– – ﹤0.01% 1522
2023
Q3 		$27.9K Hold
21,429
– – ﹤0.01% 1437
2023
Q2 		$34.7K Hold
21,429
– – ﹤0.01% 1439
2023
Q1 		$45.6K Hold
21,429
– – ﹤0.01% 1427
2022
Q4 		$79.3K Buy
+21,429
New +$28.1K ﹤0.01% 1236
2022
Q3 		– Sell
-16,660
Closed -$13K – 1288
2022
Q2 		$13K Buy
16,660
+5,348
+47% +$3.99K ﹤0.01% 1244
2022
Q1 		$10K Buy
+11,312
New +$37.9K ﹤0.01% 1206

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Vanguard Personalized Indexing Management's PRQR Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its ProQR Therapeutics (PRQR) stake by 14% in Q2 2026, buying an estimated $4.42K and bringing the position to 22,095 shares worth $41.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Vanguard Personalized Indexing Management first reported a position in PRQR in Q1 2022 and has held it in 17 quarters since. The position peaked at $79.3K in Q4 2022. 70 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

  • Vanguard Personalized Indexing Management held 22,095 shares of ProQR Therapeutics worth $41.1K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 2,685 ProQR Therapeutics shares in Q2 2026, an estimated $4.42K.
  • ProQR Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2159 holding.
  • Vanguard Personalized Indexing Management first reported a position in ProQR Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Vanguard Personalized Indexing Management's ProQR Therapeutics position peaked at $79.3K in Q4 2022.
  • 70 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.